TSE:AEZ

43844 (AEZ.TO) - AEZ Stock Forecast, Price & News

Add

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 1,000 shs
Average Volume: 12,504 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About 43844 (AEZ.TO)

Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others. The Company's principal product candidates are Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The Company focuses on its product candidates Zoptrex and Macrilen, which are in Phase III clinical development, and on a luteinizing hormone-releasing hormone (LHRH)-disorazol Z conjugate (AEZS-138), which is in pre-clinical development in oncology and is available for partnering. The Company's direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc.

Receive AEZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 43844 (AEZ.TO) and its competitors with MarketBeat's FREE daily newsletter.

AEZ Stock News Headlines

September 25, 2022 | msn.com

Robinhood introduces new feature to earn 3% interest on brokerage cash

See More Headlines

Receive AEZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 43844 (AEZ.TO) and its competitors with MarketBeat's FREE daily newsletter.

AEZ Company Calendar

Last Earnings: 11/03/2022
Today: 1/31/2023
Next Earnings (Estimated): 3/27/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Industry: Electronic Computer Manufacturing
Sub-Industry: N/A
Sector: Manufacturing
Current Symbol: TSE:AEZ
CUSIP: N/A
CIK: N/A
Web: www.aezsinc.com
Phone: +1-843-9003223
Fax: N/A
Employees: 147,000
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 11,671,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Carolyn Egbert
Independent Chairman of the Board

Michael Ward
President, Chief Executive Officer, Director

James Clavijo (Age 52)
Chief Financial Officer

Richard Sachse M.D. Ph.D.
Senior Vice President, Chief Scientific Officer, Chief Medical Officer

Jude Dinges (Age 58)
Chief Commercial Officer, Senior Vice President

Eckhard G. Gunther Ph.D.
Vice President - Alliance Management

Michael Teifel
Vice President - Non-Clinical Sciences

John W. Sharkey Ph.D. (Age 60)
Business Development Consultant

Philip Allen Theodore (Age 64)
Corporate Secretary

David A. Dodd (Age 65)
Director

Key Competitors

View All Competitors

AEZ Stock - Frequently Asked Questions

Should I buy or sell 43844 (AEZ.TO) stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for 43844 (AEZ.TO) in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AEZ shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AEZ, but not buy additional shares or sell existing shares.
View AEZ analyst ratings or view top-rated stocks.
When is 43844 (AEZ.TO)'s next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, March 27th 2023.
View our AEZ earnings forecast.
How were 43844 (AEZ.TO)'s earnings last quarter?: 43844 (AEZ.TO) (TSE:AEZ) posted its earnings results on Thursday, November, 3rd. The biopharmaceutical company reported ($0.91) EPS for the quarter, missing the consensus estimate of ($0.87) by $0.04. The biopharmaceutical company had revenue of $2.43 million for the quarter, compared to analysts' expectations of $1.74 million.
What other stocks do shareholders of 43844 (AEZ.TO) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other 43844 (AEZ.TO) investors own include Aeterna Zentaris (AEZS), AltaGas (ALA), Dollar General (DG), Bristol-Myers Squibb (BMY), Corus Entertainment (CJR.B), Costco Wholesale (COST), Cisco Systems (CSCO), Morgan Stanley (MS), Target (TGT) and Tandem Diabetes Care (TNDM).

What is 43844 (AEZ.TO)'s stock symbol?: 43844 (AEZ.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "AEZ."
How do I buy shares of 43844 (AEZ.TO)?: Shares of AEZ stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
How much money does 43844 (AEZ.TO) make?: 43844 (AEZ.TO) (TSE:AEZ) has a market capitalization of C$0.00.
How many employees does 43844 (AEZ.TO) have?: The company employs 147,000 workers across the globe.
How can I contact 43844 (AEZ.TO)?: 43844 (AEZ.TO)'s mailing address is 315 Sigma Dr Ste 302D, SUMMERVILLE, SC 29486-7790, United States. The official website for the company is www.aezsinc.com. The biopharmaceutical company can be reached via phone at +1-843-9003223.

This page (TSE:AEZ) was last updated on 1/31/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial